← Eichor
Study identifier: NCT06747260 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

Condition: Hypoxic Ischaemic Encephalopathy (HIE) · Hypoxic Ischemic Encephalopathy of Newborn · Neonatal Encephalopathy  ·  Sponsor: Semmelweis University

PhaseEARLY_Phase 1
Planned participants10
Who can joinAll sexes, N/A to 48 Hours
Healthy volunteersNo

About this study

This is a prospective intervention single center study to evaluate the feasibility and safety of intranasal breast milk in hypoxic-ischaemic encephalopathic neonates receiving therapeutic hypothermia.

This description comes directly from the study's public registry record.

Talk to the study team

Unoke Meder, MD, PhD  ·  +36303987970  ·  mederunoke@gmail.com

Agnes Jermendy, MD, PhD  ·  +36204600798  ·  jermendy@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Division of Neonatology, Pediatric Center, Semmelweis University, Budapest, HungaryBudapest, HungaryRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06747260